Clinical studies found an association between elevated GGT levels and an increased risk of heart failure, even when values fell within the normal range [26, 27, 28]
All treatments, except liraglutide (200 g/kg), tended towards a lowering of fasting plasma glucagon levels compared to vehicle
Mean reductions of 1521% are reproducible, dose-dependent, and sustained as long as the medication continues
24 The other adverse effects of MT-1 seen in this study are similar to those previously reported
Typically, changes in BP and serum creatinine (SCr) and serum potassium levels are monitored two weeks after initiation of these agents
In CRC, combining 5FU with DNA-damaging agents oxaliplatin and/or irinotecan was an empirical choice rather than a rationally designed strategy, and no new combination partners have been added since the introduction of the biological EGFR and VEGF-targeting agents in the early 2000s